
Helicobacter Pylori - IgA antibody









The Helicobacter Pylori - IgA antibody test helps detect immunoglobulin A (IgA) antibodies against Helicobacter Pylori (H. pylori), a type of bacteria that primarily causes gastrointestinal conditions. This test helps diagnose recent or ongoing H. pylori infections, helping in their timely and effective management.













Understanding Helicobacter Pylori - IgA antibody
Helicobacter pylori (H. pylori) infection is a common bacterial infection that primarily affects the stomach lining and the upper part of the small intestine. This infection, often acquired in childhood, can be asymptomatic but frequently leads to gastrointestinal issues such as gastritis, peptic ulcers, gastric mucosa-associated lymphoid tissue (MALT) lymphoma, and an increased risk of stomach cancer. Due to its asymptomatic nature, or non-specific symptoms that overlap with other gastrointestinal conditions, its diagnosis can be challenging without specific laboratory testing.
The Helicobacter Pylori - IgA antibody test helps detect Immunoglobulin A (IgA) antibodies against H. pylori bacteria in the blood. IgA is the predominant antibody found in mucosal membranes such as the lining of the stomach and intestines. This antibody plays a crucial role in mucosal immunity, providing a first line of defense against H. pylori that enter the body through mucosal surfaces. Therefore, determining the presence of H. pylori-specific IgA antibodies in blood suggests an active or recent infection.
Consider getting tested when you have gastrointestinal symptoms such as burning, pain and tenderness in the abdomen, recurrent stomach pain, nausea, indigestion, unexplained weight loss, bloating, and intestinal bleeding. This test can also be useful for initial screening in individuals who have a history of gastrointestinal discomfort or ulcers. Additionally, a doctor may recommend this test if you have risk factors associated with H. pylori-related conditions, such as a family history of gastric cancer or a personal history of gastrointestinal diseases.
It is important to note that the Helicobacter Pylori - IgA antibody test does not confirm the presence of gastrointestinal disease and therefore, should not be used as a sole criteria for the diagnosis of H. pylori-associated gastrointestinal infections. Doctors may recommend a few other tests in conjunction with the Helicobacter Pylori - IgA antibody test to confirm the diagnosis.
No special preparation is needed for the Helicobacter Pylori - IgA antibody test. However, it is important to provide a brief clinical history or doctor's prescription at the time of sample collection. Also, inform your doctor about any medications supplements, or medical conditions before the test as these factors may potentially influence the test results.
Lab test results may vary across different laboratories. Abnormal test results require an expert interpretation; therefore, never try to self-medicate at home based solely on these results, and always consult a doctor for a proper understanding of the test results. The insights from this test help the doctor tailor an appropriate treatment plan. Although maintaining good hygiene by washing hands thoroughly, eating hygienically prepared food, and drinking water from a safe, clean source are some ways to prevent an H. pylori infection, particularly in children.
Please note: This is an outsourced test. The sample for this test is collected by TATA 1MG and processed at a NABL accredited partnered lab.
What does Helicobacter Pylori - IgA antibody measure?
The Helicobacter Pylori - IgA antibody test is a blood test that detects the presence of immunoglobulin A (IgA) antibodies specific to Helicobacter pylori, a bacteria linked to stomach ulcers, gastritis, and an increased risk of stomach cancer. This test helps in diagnosing current or recent H. pylori infections by detecting the presence of IgA antibodies, which are found in mucosal membranes and known to provide mucosal immunity.
The test results provide crucial information for individuals and doctors, aiding in the assessment of the risk of H. pylori-related conditions like peptic ulcers or gastric cancer. By detecting the infection, this test guides treatment decisions and enables monitoring of treatment response over time. This test empowers individuals to take proactive steps in managing their gastrointestinal health and minimizing the risk of associated complications.





FAQs related to Helicobacter Pylori - IgA antibody
- Helicobacter pylori (H. pylori) and Cancer [Internet]. NIH; National Cancer Institute. [Accessed 23 May 2024]. Available from:
- Jaskowski TD, Martins TB, Hill HR, Litwin CM. Immunoglobulin A antibodies to Helicobacter pylori. J Clin Microbiol. 1997 Nov;35(11):2999-3000. [Accessed 23 May 2024]. Available from:
- Hayashi S, Sugiyama T, Yokota K, Isogai H, Isogai E, Oguma K, Asaka M, Fujii N, Hirai Y. Analysis of immunoglobulin A antibodies to Helicobacter pylori in serum and gastric juice in relation to mucosal inflammation. Clin Diagn Lab Immunol. 1998 Sep;5(5):617-21. [Accessed 23 May 2024]. Available from:
- Parikh NS, Ahlawat R. Helicobacter Pylori. [Updated 2023 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from:
- Wang YK, Kuo FC, Liu CJ, Wu MC, Shih HY, Wang SS, Wu JY, Kuo CH, Huang YK, Wu DC. Diagnosis of Helicobacter pylori infection: Current options and developments. World J Gastroenterol. 2015 Oct 28;21(40):11221-35. [Accessed 23 May 2024]. Available from:
- Öztekin M, Yılmaz B, Ağagündüz D, Capasso R. Overview of Helicobacter pylori Infection: Clinical Features, Treatment, and Nutritional Aspects. Diseases. 2021 Sep 23;9(4):66. [Accessed 23 May 2024]. Available from:
- She RC, Wilson AR, Litwin CM. Evaluation of Helicobacter pylori Immunoglobulin G (IgG), IgA, and IgM serologic testing compared to stool antigen testing. Clin Vaccine Immunol. 2009 Aug;16(8):1253-5. [Accessed 23 May 2024]. Available from:
- Locatelli A, Catapani WR, Gomes CR Jr, Silva CB, Waisberg J. Detection of anti-Helicobacter pylori antibodies in serum and duodenal fluid in peptic gastroduodenal disease. World J Gastroenterol. 2004 Oct 15;10(20):2997-3000. [Accessed 23 May 2024]. Available from:
- Li S, Lu AP, Zhang L, Li YD. Anti-Helicobacter pylori immunoglobulin G (IgG) and IgA antibody responses and the value of clinical presentations in diagnosis of H. pylori infection in patients with precancerous lesions. World J Gastroenterol. 2003 Apr;9(4):755-8. [Accessed 23 May 2024]. Available from:
Other tests
- CBC (Complete Blood Count)
- FBS (Fasting Blood Sugar)
- Thyroid Profile Total (T3, T4 & TSH)
- HbA1c (Glycosylated Hemoglobin)
- PPBS (Postprandial Blood Sugar)
- Lipid Profile
- Vitamin D (25-Hydroxy)
- Urine R/M (Urine Routine & Microscopy)
- Coronavirus Covid -19 test- RT PCR
- LFT (Liver Function Test)
- KFT (Kidney Function Test)
- TSH (Thyroid Stimulating Hormone) Ultrasensitive
- ESR (Erythrocyte Sedimentation Rate)
- Uric Acid, Serum
- Vitamin B12
- CRP (C-Reactive Protein), Quantitative
- Urine C/S (Urine Culture and Sensitivity)
- Serum Electrolytes
- Serum Calcium
- Serum Creatinine
- Diabetes Screening (HbA1C & Fasting Sugar)
- KFT with Electrolytes (Kidney Function Test with Electrolytes)
- Cholesterol - Total
- Hb (Hemoglobin)
- Complete Hemogram (CBC & ESR)






















